Niagen Bioscience, Inc. (NAGE)
2.065
-0.07
(-3.28%)
USD |
NASDAQ |
Nov 13, 16:00
2.065
0.00 (0.00%)
After-Hours: 19:59
Niagen Bioscience Enterprise Value : 101.30M for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 101.30M |
| November 11, 2026 | 98.14M |
| November 10, 2026 | 102.48M |
| November 09, 2026 | 112.76M |
| November 06, 2026 | 96.16M |
| November 05, 2026 | 98.93M |
| November 04, 2026 | 131.72M |
| November 03, 2026 | 119.08M |
| November 02, 2026 | 122.24M |
| October 30, 2026 | 116.71M |
| October 29, 2026 | 130.14M |
| October 28, 2026 | 133.30M |
| October 27, 2026 | 130.14M |
| October 26, 2026 | 125.40M |
| October 23, 2026 | 124.61M |
| October 22, 2026 | 131.72M |
| October 21, 2026 | 127.77M |
| October 20, 2026 | 130.93M |
| October 19, 2026 | 130.14M |
| October 16, 2026 | 129.35M |
| October 15, 2026 | 136.47M |
| October 14, 2026 | 132.51M |
| October 13, 2026 | 136.47M |
| October 12, 2026 | 140.42M |
| October 09, 2026 | 145.16M |
| Date | Value |
|---|---|
| October 08, 2026 | 142.79M |
| October 07, 2026 | 147.53M |
| October 06, 2026 | 145.16M |
| October 05, 2026 | 144.37M |
| October 02, 2026 | 153.06M |
| October 01, 2026 | 144.37M |
| September 30, 2026 | 163.34M |
| September 29, 2026 | 168.37M |
| September 28, 2026 | 170.73M |
| September 25, 2026 | 176.26M |
| September 24, 2026 | 173.10M |
| September 23, 2026 | 172.31M |
| September 22, 2026 | 179.41M |
| September 21, 2026 | 175.47M |
| September 18, 2026 | 171.52M |
| September 17, 2026 | 171.52M |
| September 16, 2026 | 172.31M |
| September 15, 2026 | 172.31M |
| September 14, 2026 | 175.47M |
| September 11, 2026 | 175.47M |
| September 10, 2026 | 175.07M |
| September 09, 2026 | 176.26M |
| September 08, 2026 | 180.20M |
| September 04, 2026 | 185.73M |
| September 03, 2026 | 180.99M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Nature's Sunshine Products, Inc. | 110.38M |
| Cyanotech Corp. | 15.05M |
| Mannatech, Inc. | 17.69M |
| Natural Alternatives International, Inc. | 48.46M |
| USANA Health Sciences, Inc. | 99.45M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.173M |
| Revenue (Quarterly) | 27.19M |
| Total Expenses (Quarterly) | 28.36M |
| EPS Diluted (Quarterly) | -0.0148 |
| Gross Profit Margin (Quarterly) | 62.90% |
| Profit Margin (Quarterly) | -4.31% |
| Earnings Yield | 5.84% |
| Operating Earnings Yield | 1.64% |
| Normalized Earnings Yield | 5.835 |